Tecartus
Tecartus is a medicine authorised by Swissmedic under authorisation number 67884. The authorisation holder is Gilead Sciences Switzerland Sàrl. The medicinal product code is Transplant: gene therapy product and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 August 2021 and the authorisation is valid without a time limit. ATC code L01XL06 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67884 |
|---|---|
| Name | Tecartus |
| Full name | Tecartus, Infusionsdispersion |
| Authorisation holder | Gilead Sciences Switzerland Sàrl |
| Medicinal product code | Transplant: gene therapy product |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XL06 |
| First authorisation | 25 August 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tecartus, Infusionsdispersion | A | 25 August 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Beutel | L01XL06 | 07.16.4. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tecartus authorised in Switzerland?
Yes. Tecartus is authorised by Swissmedic under authorisation number 67884, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tecartus have?
Tecartus is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tecartus?
The authorisation holder is Gilead Sciences Switzerland Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.